Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma via m6A-mediated epitranscriptomic regulation

20 Sep 2023
0

Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma via m6A-mediated epitranscriptomic regulation

Hung MH, Chang CW, Wang KC, Chaisaingmongkol J, Ruchirawat M, Greten, T, Wang XW

Hepatology. 2023.
(In press)

Tags

Share this

Related Posts

Sulforaphane, a cancer chemopreventive agent, induces pathways associated with membrane biosynthesis in response to tissue damage by aflatoxin B. Techapiesancharoenkij, N., Fiala, J. L. A., Navasumrit, P., Croy, R. G., Wogan, G. N., Groopman, J. D., Essigmann, J. M. (2015). Toxicology and Applied Pharmacology, 282(1), 52-60.
Disadee, W., Mahidol, C., Sahakitpichan, P., Sitthimonchai, S., Ruchirawat, S., & Kanchanapoom, T. (2011). Flavonol 3-O-robinobiosides and 3-O-(2″-O-α-rhamnopyranosyl)-robinobiosides from Sesuvium portulacastrum. Tetrahedron, 67(23), 4221-4226. https://doi.org/10.1016/j.tet.2011.04.041

Recent Posts